Text Messaging Support for Dementia Caregivers
(CAPTURE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to assist caregivers of older adults with cognitive impairment after their loved ones leave the emergency department. It evaluates a text-messaging program called CAPTURE Text Message Care Transition Support, which delivers helpful tips, emotional support, and resources directly to caregivers' phones for 30 days. Caregivers who look after someone with cognitive challenges and have a mobile phone for text messages might find this trial beneficial. Participants will provide feedback on the usefulness and ease of the text messages. As an unphased trial, this study offers caregivers a unique opportunity to contribute to innovative support solutions and enhance care transitions.
Do I have to stop taking my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It seems unlikely that you would need to stop, as the study focuses on text messaging support for caregivers.
What prior data suggests that the CAPTURE Text Message Care Transition Support is safe for caregivers?
Research has shown that text messaging support systems for caregivers, like the CAPTURE program, are generally safe and well-received. Studies on similar programs, such as CuidaTEXT, have found that caregivers benefit from supportive text messages without any reported negative effects. These programs help reduce stress and improve caregivers' ability to manage changes in care.
The CAPTURE program sends up to two text messages per day to caregivers, offering tips and emotional support. This approach relies on feedback from caregivers and health professionals, ensuring the messages are useful and relevant. Since the program is non-invasive and focuses on providing information and support, it is unlikely to cause harm.
Overall, previous studies on text-based caregiver support suggest that these programs are safe and helpful, enhancing caregivers' experiences during challenging times.12345Why are researchers excited about this trial?
Researchers are excited about the CAPTURE Text Message Care Transition Support because it offers a personalized and accessible approach to helping dementia caregivers. Unlike standard care options, which might include instructions and referrals from emergency department staff, CAPTURE provides tailored, automated text messages directly to caregivers. These messages offer daily tips, emotional support, and links to trusted resources, making the support more immediate and relevant to each caregiver's unique needs. This innovative method of delivery aims to enhance caregiver preparedness and satisfaction in a way that's easy to use and integrate into daily life.
What evidence suggests that the CAPTURE Text Message Care Transition Support is effective for dementia caregivers?
Research has shown that text message support can greatly benefit caregivers of people with dementia. Studies have found that these messages improve caregivers' well-being by providing helpful tips, emotional support, and resource links. For instance, one study found that text messages made caregivers feel more prepared and less stressed. Another study showed that caregivers appreciated the personalized and easily accessible messages. In this trial, participants in the intervention arm will receive the CAPTURE Text Message Care Transition Support, which may effectively assist caregivers during challenging times following an emergency department visit.12367
Who Is on the Research Team?
Cameron Gettel
Principal Investigator
Yale University
Are You a Good Fit for This Trial?
This trial is for adults who care for someone with cognitive impairment (like dementia) living at home, after that person has been seen and discharged from the emergency department. Caregivers must be able to read English or Spanish, have a mobile phone that can get texts, and agree to join the study.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive the CAPTURE text messaging intervention for 30 days following an ED discharge, with up to two daily SMS messages providing caregiving tips, care transition guidance, emotional support, and links to resources.
Follow-up
Participants complete a 30-day follow-up survey to assess caregiver preparedness, usability, satisfaction, and engagement.
What Are the Treatments Tested in This Trial?
Interventions
- CAPTURE Text Message Care Transition Support
Trial Overview
The study is testing a text message support program called CAPTURE to help caregivers manage care transitions after their loved one leaves the emergency department. The goal is to see if these messages improve caregiver experience and patient outcomes.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Participants in the intervention arm will receive the CAPTURE intervention, a tailored, automated text messaging program designed to support care partners of persons living with cognitive impairment (PLWCI) during the 30 days following an emergency department (ED) discharge. The intervention delivers up to two daily SMS messages focused on caregiving tips, care transition guidance, emotional support, and links to trusted resources. Messages are personalized based on caregiver needs identified at baseline and are designed to be brief, accessible, and actionable. Content was developed using a user-centered design approach with input from caregivers and clinicians. Participants will also complete a baseline and 30-day follow-up survey to assess caregiver preparedness, usability, satisfaction, and engagement.
Participants in the control arm will receive usual care following the emergency department (ED) discharge of the person living with cognitive impairment (PLWCI). Usual care may include standard discharge instructions provided by ED staff, referrals to outpatient services, and any follow-up arranged as part of routine clinical practice. No additional caregiver-specific interventions or text messaging support will be provided by the study team. Participants in this arm will complete a baseline and 30-day follow-up survey to assess caregiver preparedness, usability, satisfaction, and engagement for comparison with the intervention arm.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Yale University
Lead Sponsor
National Institute on Aging (NIA)
Collaborator
Citations
ED PLWD/Care Partner Text Messaging (CAPTURE)
The CAPTURE intervention is a tailored, automated text messaging program designed to support care partners of persons living with cognitive ...
Dementia Caregivers' Perspectives on Technology's Place in ...
The present study sought to assess the experiences of informal caregivers who provide care for PLWD. In contrast to a deficit-focused approach, ...
Development and validation of the Caregiver‐reported ...
We developed and validated the Caregiver-reported Outcome Measure for Emergency care Transitions (COMET) tool to assess these transitions.
NIH-funded study to test the effects of first text-message ...
NIH-funded study to test the effects of first text-message support intervention for Latino caregivers of people with dementia. CuidaTEXT ...
Effect of Collaborative Dementia Care via Telephone ... - PMC
This study demonstrated that collaborative dementia care provided from a centralized hub via telephone and internet can improve caregiver well-being within 6 ...
CuidaTXT: a Text Message Dementia-caregiver ...
The overall aim of this proposal is to develop and test the first text message intervention for caregiver support of individuals with dementia among Latinos.
A Text Messaging Intervention to Support Latinx Family ... - PMC
This study aimed to describe the development of CuidaTEXT, a tailored SMS text messaging intervention to support Latinx family caregivers of individuals with ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.